TRANSMEDICS GROUP INC (TMDX) Stock Fundamental Analysis
NASDAQ:TMDX - US89377M1099 - Common Stock
117.95 USD
+2.77 (+2.4%)
Taking everything into account, TMDX scores 6 out of 10 in our fundamental rating. TMDX was compared to 185 industry peers in the Health Care Equipment & Supplies industry. TMDX has an average financial health and profitability rating. TMDX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, TMDX could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
TMDX had positive earnings in the past year.
TMDX had a positive operating cash flow in the past year.
In the past 5 years TMDX reported 4 times negative net income.
In the past 5 years TMDX reported 4 times negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.05%, TMDX belongs to the top of the industry, outperforming 90.81% of the companies in the same industry.
TMDX's Return On Equity of 22.53% is amongst the best of the industry. TMDX outperforms 94.59% of its industry peers.
TMDX's Return On Invested Capital of 7.25% is amongst the best of the industry. TMDX outperforms 82.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROIC | 7.25% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TMDX has a better Profit Margin (13.49%) than 89.19% of its industry peers.
With an excellent Operating Margin value of 14.41%, TMDX belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
The Gross Margin of TMDX (59.79%) is comparable to the rest of the industry.
TMDX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
TMDX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TMDX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TMDX has been increased compared to 5 years ago.
Compared to 1 year ago, TMDX has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.03 indicates that TMDX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.03, TMDX belongs to the top of the industry, outperforming 80.54% of the companies in the same industry.
TMDX has a debt to FCF ratio of 29.44. This is a negative value and a sign of low solvency as TMDX would need 29.44 years to pay back of all of its debts.
TMDX has a better Debt to FCF ratio (29.44) than 67.03% of its industry peers.
A Debt/Equity ratio of 1.61 is on the high side and indicates that TMDX has dependencies on debt financing.
The Debt to Equity ratio of TMDX (1.61) is worse than 84.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Altman-Z | 5.03 |
ROIC/WACC0.9
WACC8.1%
2.3 Liquidity
A Current Ratio of 9.86 indicates that TMDX has no problem at all paying its short term obligations.
TMDX has a Current ratio of 9.86. This is amongst the best in the industry. TMDX outperforms 92.43% of its industry peers.
TMDX has a Quick Ratio of 9.10. This indicates that TMDX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 9.10, TMDX belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 |
3. Growth
3.1 Past
TMDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4725.00%, which is quite impressive.
TMDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.09%.
The Revenue has been growing by 79.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
3.2 Future
Based on estimates for the next years, TMDX will show a very strong growth in Earnings Per Share. The EPS will grow by 49.75% on average per year.
TMDX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.19% yearly.
EPS Next Y138.21%
EPS Next 2Y66.18%
EPS Next 3Y53.31%
EPS Next 5Y49.75%
Revenue Next Year39.73%
Revenue Next 2Y29.92%
Revenue Next 3Y25.96%
Revenue Next 5Y21.19%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 61.11, which means the current valuation is very expensive for TMDX.
67.03% of the companies in the same industry are more expensive than TMDX, based on the Price/Earnings ratio.
TMDX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.08.
The Price/Forward Earnings ratio is 42.29, which means the current valuation is very expensive for TMDX.
TMDX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 69.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, TMDX is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.11 | ||
| Fwd PE | 42.29 |
4.2 Price Multiples
68.11% of the companies in the same industry are more expensive than TMDX, based on the Enterprise Value to EBITDA ratio.
TMDX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 67.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 231.73 | ||
| EV/EBITDA | 40.25 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TMDX's earnings are expected to grow with 53.31% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y66.18%
EPS Next 3Y53.31%
5. Dividend
5.1 Amount
No dividends for TMDX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:TMDX (8/27/2025, 1:52:06 PM)
117.95
+2.77 (+2.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners121.6%
Inst Owner Change-6.21%
Ins Owners2.98%
Ins Owner Change11.98%
Market Cap4.02B
Analysts81.25
Price Target154.02 (30.58%)
Short Float %23.38%
Short Ratio7.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.71%
Min EPS beat(2)100.04%
Max EPS beat(2)167.38%
EPS beat(4)3
Avg EPS beat(4)55.99%
Min EPS beat(4)-59.86%
Max EPS beat(4)167.38%
EPS beat(8)6
Avg EPS beat(8)145.25%
EPS beat(12)10
Avg EPS beat(12)114.95%
EPS beat(16)11
Avg EPS beat(16)83.13%
Revenue beat(2)2
Avg Revenue beat(2)9.07%
Min Revenue beat(2)4.34%
Max Revenue beat(2)13.8%
Revenue beat(4)3
Avg Revenue beat(4)4.75%
Min Revenue beat(4)-7.28%
Max Revenue beat(4)13.8%
Revenue beat(8)7
Avg Revenue beat(8)11.77%
Revenue beat(12)11
Avg Revenue beat(12)15.17%
Revenue beat(16)14
Avg Revenue beat(16)17.24%
PT rev (1m)0.75%
PT rev (3m)28.51%
EPS NQ rev (1m)11.93%
EPS NQ rev (3m)-5.4%
EPS NY rev (1m)30.57%
EPS NY rev (3m)33.88%
Revenue NQ rev (1m)2.32%
Revenue NQ rev (3m)6.41%
Revenue NY rev (1m)3.57%
Revenue NY rev (3m)4.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.11 | ||
| Fwd PE | 42.29 | ||
| P/S | 7.57 | ||
| P/FCF | 231.73 | ||
| P/OCF | 34.88 | ||
| P/B | 12.64 | ||
| P/tB | 13.2 | ||
| EV/EBITDA | 40.25 |
EPS(TTM)1.93
EY1.64%
EPS(NY)2.79
Fwd EY2.36%
FCF(TTM)0.51
FCFY0.43%
OCF(TTM)3.38
OCFY2.87%
SpS15.58
BVpS9.33
TBVpS8.93
PEG (NY)0.44
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROCE | 9.18% | ||
| ROIC | 7.25% | ||
| ROICexc | 13.96% | ||
| ROICexgc | 14.41% | ||
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% | ||
| FCFM | 3.27% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
F-Score7
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Debt/EBITDA | 5.09 | ||
| Cap/Depr | 412.74% | ||
| Cap/Sales | 18.43% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 114.93% | ||
| Profit Quality | 24.21% | ||
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 | ||
| Altman-Z | 5.03 |
F-Score7
WACC8.1%
ROIC/WACC0.9
Cap/Depr(3y)951.97%
Cap/Depr(5y)615.69%
Cap/Sales(3y)34.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
EPS Next Y138.21%
EPS Next 2Y66.18%
EPS Next 3Y53.31%
EPS Next 5Y49.75%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
Revenue Next Year39.73%
Revenue Next 2Y29.92%
Revenue Next 3Y25.96%
Revenue Next 5Y21.19%
EBIT growth 1Y6324.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.7%
EBIT Next 3Y89.1%
EBIT Next 5Y68.38%
FCF growth 1Y142.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y451.66%
OCF growth 3YN/A
OCF growth 5YN/A